KYKOY 주가 차트
KYKOY 재무
Kyowa Kirin Co., Ltd.
$16.69
0%
$0
종가: May 08, 16:00:00 GMT-4
$16.69
0%
$0
애프터마켓: May 08, 20:00:00 GMT-4
뒤로
Kyowa Kirin Co., Ltd. (KYKOY) 재무
수입
자산 및 부채 명세서
현금 흐름
연간
분기별
KYKOY 소득
미화 수백만 달러. 회계 연도는 2월부터 1월까지입니다.
Follow-Up Questions
Kyowa Kirin Co., Ltd.의 주요 재무제표는 무엇인가요?
KYKOY의 주요 재무 비율은 무엇인가요?
Kyowa Kirin Co., Ltd.의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Kyowa Kirin Co., Ltd.은 수익성이 있나요?
Kyowa Kirin Co., Ltd.에 부채가 있나요?
Kyowa Kirin Co., Ltd.의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$16.69
시가
$16.75
일일 범위
$16.69 - $16.75
52주 범위
$14.35 - $18.66
거래량
100
평균 거래량
191
배당수익률
--
EPS(TTM)
0.81
시가총액
$8.7B
Kyowa Hakko Kogyo Co., Ltd.란 무엇인가요?
Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 5,161 full-time employees. The firm operates in Pharmaceuticals business segment. The firm engages in the research, development, manufacture, sale, and import & export of prescription pharmaceuticals. The firm has drug discovery technologies in antibody therapeutics and hematopoietic stem cell gene therapy. Its development pipeline includes AMG531 for aplastic anemia untreated with immunosuppressive therapy, KHK4083/AMG 451 for moderate to severe atopic dermatitis, KHK4083/AMG 451 for moderate to severe asthma, and KK2845 for acute myeloid leukemia and others. In addition, through its subsidiaries, the Company develops, manufactures, markets, and contracts out biosimilar pharmaceuticals, and engages in wholesale and retail sales and insurance agency business. The firm operates in Japan and overseas.
